Hydrafacial Results Presentation Deck
Top line Q3 results exceed expectations despite
macroeconomic environment
5
Strong top line
品
$88.8mm net sales
+30% growth YoY
$16.5mm adjusted EBITDA¹
($0.1mm GAAP net income)
Mid double-digit net sales
growth in every region
YoY growth:
Americas:
APAC:
EMEA:
+30%
+44%
+21%
Updating 2022
guidance
A
$360 - $365mm net sales
$45 - $50mm adjusted EBITDA²
Continued confidence in long-term execution plan
BEAUTYHEALTH™
1. Non-GAAP measure; refer to appendix for reconciliation of most appropriate GAAP measure.
2. Our achievement of the anticipated results is subject to risks and uncertainties, including those disclosed in our filings with the SEC. The plan does not take into account the impact of any unanticipated developments in the business or changes in the operating environment, nor does it take into
account the impact of our acquisitions, dispositions or financings during 2022. Our plan assumes a largely reopened global market, which would be negatively impacted if closures or other restrictive measures persist or are reimplemented.View entire presentation